Australian Pharmaceutical Formulary

From WikiMD's WELLNESSPEDIA

Australian Pharmaceutical Formulary (APF) is a comprehensive, authoritative guide for the Australian pharmacy profession. It provides a wide range of information and guidance on professional pharmacy practice, including the use, formulation, and dispensing of medicines and healthcare products.

Overview[edit]

The Australian Pharmaceutical Formulary is published by the Pharmaceutical Society of Australia (PSA). It is updated regularly to ensure it remains current and relevant to the evolving needs of the pharmacy profession and the wider healthcare sector. The APF is widely recognized as a key resource for pharmacists, pharmacy students, and other healthcare professionals in Australia.

Content[edit]

The APF contains a wealth of information on a wide range of topics, including:

  • Pharmaceutical compounding: The APF provides detailed guidance on the compounding of medicines, including the use of appropriate ingredients, equipment, and techniques.
  • Drug interactions: The APF includes information on potential drug interactions, helping pharmacists to ensure the safe and effective use of medicines.
  • Therapeutic guidelines: The APF provides guidance on the therapeutic use of medicines, based on the latest evidence and best practice.
  • Professional standards: The APF sets out the professional standards and ethical guidelines for pharmacists in Australia.

Use in Pharmacy Practice[edit]

The APF is used by pharmacists in a variety of settings, including community pharmacies, hospital pharmacies, and in academia. It is also used by pharmacy students as a key reference in their studies.

Editions[edit]

The APF is currently in its 24th edition, which was published in 2018. Each edition of the APF is updated to reflect changes in medicine, pharmacy practice, and healthcare policy.

See Also[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Australian_Pharmaceutical_Formulary&oldid=5373326"